Table 1 Characteristics of continuous ambulatory peritoneal dialysis patients with or without depressive symptoms
Characteristics of patients | Non-depressive symptoms group | Depressive symptoms group | p -value |
|---|---|---|---|
N | 29 | 103 | / |
Men, n(%) | 20(69.0) | 57(55.3) | 0.189 |
Age, years | 55.0(48.0-60.5) | 59.0(48.0–69.0) | 0.108 |
Married | 27(93.1) | 91(88.3) | 0.464 |
Employed | 7(24.1) | 12(11.7) | 0.092 |
Current Smoking | 3(10.3) | 9(8.7) | 0.791 |
Current Alcohol Drinker | 2(6.9) | 5(4.9) | 0.666 |
CAPD Vintage, months | 36.0(15.5–63.5) | 26.0(9.0–55.0) | 0.095 |
Hypertension, n(%) | 28(96.6) | 99(96.1) | 0.914 |
Diabetes Mellitus, n(%) | 9(31.0) | 51(49.5) | 0.077 |
History of CVD, n(%) | 5(17.2) | 29(28.2) | 0.237 |
BMI, Kg/m2 | 22.15(20.76–25.25) | 22.72(20.70-24.44) | 0.727 |
Systolic blood pressure, mmHg | 140(120–160) | 140(130–152) | 0.923 |
Diastolic blood pressure, mmHg | 82(79–90) | 80(70–90) | 0.150 |
Kt/V | 1.47(1.26–1.77) | 1.73(1.34–2.10) | 0.072 |
Laboratory Values | |||
Hemoglobin, g/L | 110(86–147) | 105(90–120) | 0.432 |
Albumin, g/dL | 32.8(29.1–38.0) | 34.0(30.9–38.0) | 0.833 |
Blood urea nitrogen, mmol/L | 21.1(18.4–25.4) | 19.9(14.4–24.2) | 0.087 |
Creatinine, µmol/L | 995.0(848.5–1194.0) | 934.0(707.0-1128.0) | 0.151 |
Total Cholesterol, mg/dL | 4.0(3.1–4.9) | 3.88(3.13–4.75) | 0.836 |
Triglycerides, mg/dL | 1.05(0.78–2.05) | 1.36(0.86–2.78) | 0.245 |
HDL-C, mg/dL | 0.98(0.87–1.12) | 1.08(0.76–1.30) | 0.854 |
LDL-C, mg/dL | 2.49(1.81–3.14) | 2.03(1.76–2.88) | 0.142 |
C reactive protein, mg/dL | 2.97(1.16–5.22) | 2.37(0.71–6.48) | 0.625 |
Calcium, mmol/L | 2.11(1.96–2.25) | 2.18(2.05–2.30) | 0.303 |
Phosphorus, mmol/L | 1.85(1.67–2.35) | 1.67(1.37–2.12) | 0.105 |
Potassium, mmol/L | 4.4(3.4–4.8) | 4.1(3.4–4.85) | 0.831 |
Total Bilirubin, µmol/L | 6.3(4.1–8.5) | 6.2(4.8–8.8) | 0.466 |
Alanine Amino-transferase, U/L | 12.9(9.2–19.1) | 11.0(7.2–15.9) | 0.256 |
Aspartate Amino-transferase, U/L | 14.0(11.5–17.0) | 14.3(10.5–19.6) | 0.945 |
Parathyroid hormone, pg/ml | 29.7(18.4–46.7) | 29.2(13.5–42.5) | 0.468 |
Brainnatriuretic peptide, pg/ml | 16,000(3990–35,000) | 8440(1980–19,200) | 0.883 |
Medication, n(%) | |||
CCB | 26(89.7) | 89(86.4) | 0.645 |
ARB or ACEi | 20(69.0) | 55(53.4) | 0.135 |
β-receptor Blocker | 12(41.4) | 57(55.3) | 0.184 |
Aspirin | 5(17.2) | 21(20.4) | 0.707 |
Weekly dose of Erythropoietin, U | 10,000(6000–10,000) | 10,000(10,000–10,000) | 0.464 |
Statins | 14(48.3) | 49(47.6) | 0.868 |